| 000 | 01058 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250513034442.0 | ||
| 264 | 0 | _c19950825 | |
| 008 | 199508s 0 0 eng d | ||
| 022 | _a0077-8923 | ||
| 024 | 7 |
_a10.1111/j.1749-6632.1995.tb44455.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDecker, M D | |
| 245 | 0 | 0 |
_aIssues in design of clinical trials of combination vaccines. _h[electronic resource] |
| 260 |
_bAnnals of the New York Academy of Sciences _cMay 1995 |
||
| 300 |
_a234-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAntibody Formation |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xstandards |
| 650 | 0 | 4 |
_aVaccines, Combined _xadverse effects |
| 700 | 1 | _aEdwards, K M | |
| 773 | 0 |
_tAnnals of the New York Academy of Sciences _gvol. 754 _gp. 234-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1749-6632.1995.tb44455.x _zAvailable from publisher's website |
| 999 |
_c7625094 _d7625094 |
||